Skip to content

Drug interactions

Olaparib + Topotecan

Severity: Major

Olaparib and Topotecan: major interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Both agents cause bone marrow suppression, and combining them can lead to more severe and prolonged neutropenia, anemia and thrombocytopenia. Combination regimens usually require dose reductions.

What this interaction means in plain words

Olaparib and Topotecan can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Olaparib belongs to Oncology; Topotecan belongs to Oncology.

Evidence level: Moderate

Why it happens

Additive myelosuppression, with PARP inhibition potentiating topoisomerase I inhibitor DNA damage.

What to do

Use only within a monitored protocol, with frequent complete blood counts and reduced doses of one or both drugs. Delay treatment or use growth factor support for significant cytopenias.

What to ask your pharmacist

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Olaparib and Topotecan, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Olaparib with Topotecan?

MediHelp rates the interaction as major. Olaparib and Topotecan can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Both agents cause bone marrow suppression, and combining them can lead to more severe and prolonged neutropenia, anemia and thrombocytopenia. Combination regimens usually require dose reductions.

How serious is the interaction between Olaparib and Topotecan?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Use only within a monitored protocol, with frequent complete blood counts and reduced doses of one or both drugs. Delay treatment or use growth factor support for significant cytopenias.

What other medicines interact with Topotecan?

MediHelp also lists interactions of Topotecan with, for example, Adenovirus types 4 and 7 live, Amiodarone, Cisplatin. The full list is on the Topotecan page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in